Snapshot from Jul 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Vivani and Novo Nordisk Agreement
Business partnership agreement

Vivani and Novo Nordisk Agreement

Analysis based on 7 articles · First reported Jul 07, 2026 · Last updated Jul 07, 2026

Sentiment
30
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The agreement signals Novo Nordisk's interest in Vivani's technology, potentially boosting Vivani's stock. However, the non-exclusive nature limits immediate revenue impact. The planned Phase 1 study adds a catalyst for mid-2026.

biotechnology pharmaceuticals
Event Summary

Vivani Medical, Inc. announced a non-exclusive agreement with Novo Nordisk to evaluate NPM-139, Vivani's semaglutide implant for chronic weight management. The agreement allows Novo Nordisk to internally evaluate the implant, which uses Vivani's NanoPortal platform. No exclusivity provisions are included. Separately, Vivani plans to initiate a Phase 1 first-in-human study of NPM-139 in mid-2026, using Wegovy as an active comparator.

Key Actions
80 Vivani Medical signed agreement Novo Nordisk
70 Vivani Medical plans to initiate
Entities Involved
priv
Vivani Medical
Vivani is the central company; the agreement validates its technology and may lead to future partnerships or licensing deals.
Importance 100.0 Sentiment 40.0
stock
Novo Nordisk
Novo Nordisk gains access to evaluate a novel delivery method for semaglutide, potentially expanding its weight management portfolio.
Importance 80.0 Sentiment 10.0
per
Adam Mendelsohn
As CEO, Mendelsohn announced the agreement and expressed confidence in the technology.
Importance 30.0 Sentiment 0.0
per
Don H. Dwyer Jr.
Dwyer is the Chief Business Officer, listed as a company contact.
Importance 10.0 Sentiment 0.0
per
Jami Taylor
Taylor is the Investor and Media Relations Advisor, listed as a contact.
Importance 10.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
The SEC is mentioned in forward-looking statements; no direct impact from this event.
Importance 5.0 Sentiment 0.0
exch
Nasdaq
Vivani is listed on Nasdaq; the event may influence its stock price.
Importance 5.0 Sentiment 0.0
Relationships
United States — United States Securities and Exchange Commission related ↔ Nasdaq
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.